User menu

A Phase Ii International, Multicenter Study of Oral Panobinostat (lbh589) in Patients With Refractory Cutaneous T-cell Lymphoma (ctcl)

Bibliographic reference Bernengo, M. G. ; Vanaclocha, F. ; Duvic, M. ; Kuzel, T. ; Kerdel, F. ; et. al. A Phase Ii International, Multicenter Study of Oral Panobinostat (lbh589) in Patients With Refractory Cutaneous T-cell Lymphoma (ctcl).13th Congress of the European-Hematology-Association (Copenhagen(Denmark), Jun 12-15, 2008). In: Haematologica : the hematology journal, Vol. 93, p. 109 (2008)
Permanent URL http://hdl.handle.net/2078.1/59020